ID
45888
Beschreibung
Principal Investigator: Susan R. Heckbert, MD, PhD, University of Washington, Seattle, WA, USA MeSH: Cardiovascular Disease,Venous Thrombosis,Atrial Fibrillation https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000993 *Objectives*br The Heart and Vascular Health Study (HVH) is a case-control study of risk factors for the development of myocardial infarction (MI), stroke, venous thrombosis (VT), and atrial fibrillation (AF). The study setting is Group Health, an integrated health care delivery system in Washington State. Only VT cases and early-onset AF cases are included as part of TOPMed. *Background*br The HVH study originated in 1988 with the examination of risk factors for MI. Over the ensuing years, the study has been funded by a series of grants which have added case subjects with stroke, VT, and AF. Study aims focused on the associations of medication use with cardiovascular events, and starting in 1997, the study aims expanded to include genetic associations with cardiovascular disease. Participants recruited in 2009 or later who provided blood samples for genetic analysis were asked for consent to deposit genetic and phenotypic data in dbGaP. *Design*br As part of the HVH study, case subjects were identified by searching for ICD-9 codes consistent with MI, stroke, VT, or AF, and medical records were reviewed to confirm the diagnosis. Control subjects were identified at random from the Group Health enrollment and were matched to MI cases. All subjects have an index date. For cases, the index date was assigned as the date that the cardiovascular event (MI, stroke, VT, or AF) came to clinical attention. For controls, the index date was a random date within the range of the case index dates. For both cases and controls, information was collected from the inpatient and outpatient medical record, by telephone interview with consenting survivors, and from the Group Health pharmacy and laboratory databases. Consenting participants provided a blood specimen. *Subjects*br Only VT and early-onset AF cases from HVH are included in TOPMed. Within the HVH study, VT and AF cases were diagnosed in both inpatient and outpatient settings, and only incident cases are eligible for inclusion in TOPMed. *Genetic Research*br Genetic factors underlying cardiovascular disease are studied using DNA isolated from the blood samples. Phenotype data for HVH study participants are available through dbGaP phs001013.
Link
Stichworte
Versionen (1)
- 25.11.23 25.11.23 - Simon Heim
Rechteinhaber
Susan R. Heckbert, MD, PhD, University of Washington, Seattle, WA, USA
Hochgeladen am
25. November 2023
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
dbGaP phs000993 NHLBI TOPMed: Heart and Vascular Health Study (HVH)
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, and affection status for atrial fibrillation (AF) or venous thrombosis (VT).
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This sample attributes table includes body site where sample was collected, analyte type, tumor status, sequencing centers, funding source, TOPMed phase, project, and study name.
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, and affection status for atrial fibrillation (AF) or venous thrombosis (VT).
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This sample attributes table includes body site where sample was collected, analyte type, tumor status, sequencing centers, funding source, TOPMed phase, project, and study name.
C0680251 (UMLS CUI [1,2])
C0814120 (UMLS CUI [1,2])
C0947630 (UMLS CUI [1,3])
C2316983 (UMLS CUI [1,4])
C0004238 (UMLS CUI [2,1])
C0004239 (UMLS CUI [2,2])
C0814120 (UMLS CUI [2,3])
C0001779 (UMLS CUI [2,4])
C0686906 (UMLS CUI [2,5])
C0018799 (UMLS CUI [2,6])
C0439615 (UMLS CUI [3,1])
C0004238 (UMLS CUI [3,2])
C2700399 (UMLS CUI [3,3])
C0021562 (UMLS CUI [3,4])
C0029921 (UMLS CUI [3,5])
C0004238 (UMLS CUI [4,1])
C2316983 (UMLS CUI [4,2])
C1711411 (UMLS CUI [4,3])
C0021562 (UMLS CUI [4,4])
C0029921 (UMLS CUI [4,5])
C0730229 (UMLS CUI [4,6])
C0004238 (UMLS CUI [5,1])
C0439615 (UMLS CUI [5,2])
C1707834 (UMLS CUI [5,3])
C0543467 (UMLS CUI [5,4])
C2699488 (UMLS CUI [5,5])
C0586003 (UMLS CUI [5,6])
C2828389 (UMLS CUI [5,7])
C0004238 (UMLS CUI [6,1])
C1709305 (UMLS CUI [6,2])
C1442880 (UMLS CUI [6,3])
C0231290 (UMLS CUI [6,4])
C2700399 (UMLS CUI [6,5])
C0004238 (UMLS CUI [7,1])
C0011900 (UMLS CUI [7,2])
C0018799 (UMLS CUI [7,3])
C0018801 (UMLS CUI [7,4])
C0027051 (UMLS CUI [7,5])
C0002962 (UMLS CUI [7,6])
C0010055 (UMLS CUI [7,7])
C0190211 (UMLS CUI [7,8])
C0018824 (UMLS CUI [7,9])
C5395245 (UMLS CUI [7,10])
C0152021 (UMLS CUI [7,11])
C0848753 (UMLS CUI [7,12])
C5195258 (UMLS CUI [7,13])
C2828389 (UMLS CUI [7,14])
C0020550 (UMLS CUI [8,1])
C0032285 (UMLS CUI [8,2])
C0699757 (UMLS CUI [8,3])
C0032930 (UMLS CUI [8,4])
C0004238 (UMLS CUI [8,5])
C2828389 (UMLS CUI [8,6])
C0332240 (UMLS CUI [1,2])
C0700032 (UMLS CUI [1,3])
C0332168 (UMLS CUI [1,4])
C0011900 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0032930 (UMLS CUI [2,3])
C0006826 (UMLS CUI [2,4])
C0543467 (UMLS CUI [2,5])